Aethlon Medical, Inc. (AEMD) News
Track canonical SquawkNews coverage tagged to AEMD, Aethlon Medical, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 22 indexed stories across 12 publication days and is ordered by the same first-publication timeline used by LiveCast.
H
Aethlon Medical, Oklo, CID HoldCo, Xenon Pharmaceuticals and Moderna: Why These 5 Stocks Are on Investors' Radars Today
Major U.S. indices closed higher on Thursday, with the Dow Jones Industrial Average rising 0.61% to 51,778.04, the S&P 500 advancing 1.14% to 7,637.76 and the Nasdaq climbing 1.69% to 26,418.29. These are the top stocks
LIVE | Sep 18, 2026, 01:19 AM UTC
M
U.S. pending home sales rise 0.3% in August
U.S. pending home sales increased 0.3% month over month in August after a revised 2.6% decline in July. The reading compared with estimates for a 2.0% increase.
MACRO | Sep 17, 2026, 05:15 PM UTC
M
U.S. stocks rise as jobless claims decline
U.S. equities traded higher Thursday, with the Nasdaq up about 400 points and the S&P 500 and Dow also advancing. Initial jobless claims fell by 10,000 to 196,000 in the second week of September, versus estimates of 208,
MACRO | Sep 17, 2026, 03:42 PM UTC
M
Aethlon Medical to merge with North Immunology; PIPE about $180M
Aethlon Medical announced a definitive agreement to merge with North Immunology via a tax-free, two-step reorganization, supported by an approximately $180 million PIPE expected to fund immediately prior to closing.
EQUITY | Sep 17, 2026, 12:13 PM UTC
M
Aethlon Medical sets NOR-101 Phase 1a start for 1Q 2027
EQUITY | Sep 17, 2026, 10:37 AM UTC
M
Aethlon Medical to merge with North Immunology; ~$180M financing
Aethlon Medical entered a definitive all-stock merger with North Immunology and an oversubscribed private placement of about $180M, expected to fund operations into 2H 2028. Pre-merger Aethlon holders are expected to own
EQUITY | Sep 17, 2026, 10:34 AM UTC
M
Aethlon Medical to merge with North Immunology to advance NOR-101
North Immunology’s lead program, NOR-101, is a half-life extended anti-IL-13 x IL-18 bispecific antibody for atopic dermatitis, targeting both type 2 and non-type 2 inflammation.
EQUITY | Sep 17, 2026, 10:31 AM UTC
L
Aethlon Medical amends employment agreements for James B. Frakes and Steven P. LaRosa
Aethlon Medical amended the employment agreements of CEO/CFO James B. Frakes and Chief Medical Officer Steven P. LaRosa to provide for lump-sum severance and health care continuation payments upon a qualifying change in
REGULATION | Sep 15, 2026, 12:24 PM UTC
M
Aethlon Medical (AEMD) reports Q1 fiscal 2027 results
Aethlon Medical (AEMD) reports Q1 fiscal 2027 results and provides progress on its Hemopurifier® program, according to TradeXchange Newsdesk.
EQUITY | Aug 13, 2026, 08:15 PM UTC
L
AEMD AEMD - Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 13, 2026
AEMD AEMD - Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 13, 2026
EARNINGS | Aug 05, 2026, 12:03 PM UTC
M
AEMD Announces 1-for-5 Reverse Split
AEMD undergoes 1-for-5 reverse stock split
EQUITY | Aug 04, 2026, 09:06 AM UTC
L
AEMD Announces 1-for-5 Reverse Split
AEMD undergoes 1-for-5 reverse stock split
EQUITY | Aug 04, 2026, 12:33 AM UTC
H
AEMD Announces Reverse Stock Split
AEMD implements 1-for-5 reverse stock split
EQUITY | Jul 31, 2026, 12:04 PM UTC
L
Aethlon Medical Prices $4M Follow-On Offering Of 5,633,009 Shares And Warrants At $0.7101 Per Unit
Aethlon Medical, Inc. (NASDAQ: AEMD ), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today announced the pricing of its follow-on offering of 5,633
EQUITY | Jul 06, 2026, 01:27 PM UTC
L
Aethlon Medical Announces Pricing of $4.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules
Aethlon Medical Announces Pricing of $4.0 Million Follo
EQUITY | Jul 06, 2026, 01:25 PM UTC
L
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Curis (NASDAQ: CRIS ) stock rose 9.0% to $0.46 during Wednesday's after-market session. The company's market cap stands at $20.3 million. Humacyte (NASDAQ: HUMA ) shares moved upwards by 5.45% to $0.71. The marke
EQUITY | Jul 01, 2026, 09:05 PM UTC
L
Aethlon Medical shares are trading lower after the company filed a prospectus for a mixed shelf offering.
Aethlon Medical shares are trading lower after the company filed a prospectus for a mixed shelf offering.
EQUITY | Jul 01, 2026, 01:17 PM UTC
L
Aethlon Medical Files Prospectus For Offering Mixed Shelf
Aethlon Medical Files Prospectus For Offering Mixed Shelf
EQUITY | Jul 01, 2026, 12:49 PM UTC
L
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Alzamend Neuro (NASDAQ: ALZN ) stock increased by 12.9% to $1.35 during Tuesday's after-market session. The company's market cap stands at $4.4 million. Vivos Therapeutics (NASDAQ: VVOS ) shares increased by 9.92
GEOPOLITICS | Jun 30, 2026, 09:05 PM UTC
M
AEMD Publishes Long COVID Biomarker
Aethlon Medical announces publication demonstrating novel long COVID biomarker and potential therapeutic target for the Hemopurifier
EQUITY | Jun 26, 2026, 12:01 PM UTC
M
Healthcare Stocks Moving
Multiple healthcare stocks are moving in Monday's intraday session, with gainers including Tenon Medical and Aditxt, and losers including Aethlon Medical and Atlantic International
EQUITY | Jun 22, 2026, 05:23 PM UTC
L
AEMD Files S-1
AEMD files Form S-1 for up to 6,000,000 shares of common stock
EQUITY | Jun 22, 2026, 01:18 PM UTC